Alkermes Ownership | Who Owns Alkermes?


OverviewForecastRevenueFinancialsChartTranscripts

Alkermes Ownership Summary


Alkermes is owned by 108.34% institutional investors, 1.41% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 17.59% of ALKS shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.05% of its assets in Alkermes shares.

ALKS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlkermes108.34%1.41%-9.74%
SectorHealthcare Stocks 50.62%12.41%36.97%
IndustrySpecialty & Generic Drug Manufacturers Stocks35.37%14.85%49.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de29.24M17.59%$1.53B
Blackrock29.11M17.33%$701.49M
Vanguard group18.01M10.91%$503.85M
Baker bros. advisors lp10.01M6.02%$524.59M
State street9.16M5.51%$479.97M
Vanguard capital management7.52M4.52%$393.75M
Price t rowe associates inc /md/6.74M4.05%$353.00M
Renaissance6.46M3.89%$338.52M
Geode capital management4.48M2.69%$234.66M
Dimensional fund advisors lp4.19M2.52%$219.79M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Commodore capital lp3.00M9.36%$157.19M
Bain capital life sciences investors1.94M6.04%$101.54M
Artia global partners lp448.96K4.34%$23.52M
Prosight management, lp394.39K3.56%$20.66M
Knott david m jr121.76K3.37%$6.38M
Deep track capital, lp4.00M3.05%$209.58M
Healthinvest partners ab213.33K3.01%$11.18M
Bvf inc/il2.15M2.89%$112.90M
Bioimpact capital549.26K2.70%$16.48M
Affinity asset advisors1.13M2.66%$58.94M

Top Buyers

HolderShares% AssetsChange
Sixth street partners management company2.34M0.02%2.34M
Norges bank2.16M0.01%2.16M
Price t rowe associates inc /md/6.74M0.04%2.07M
Adage capital partners gp1.37M0.10%1.37M
Bain capital life sciences investors1.94M6.04%1.33M

Top Sellers

HolderShares% AssetsChange
Jpmorgan chase262.72K0.00%-3.84M
Hardman johnston global advisors---2.67M
American century companies3.95M0.09%-2.12M
Camber capital management lp---1.50M
Arrowstreet capital, limited partnership---1.45M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company2.34M0.02%2.34M$122.35M
Norges bank2.16M0.01%2.16M$113.01M
Adage capital partners gp1.37M0.10%1.37M$71.68M
Summit partners public asset management950.23K0.88%950.23K$49.79M
Frontier capital management659.56K0.32%659.56K$34.56M

Sold Out

HolderChange
Financial gravity asset management-1.00
Mather group, llc.-2.00
Curio wealth-3.00
Vermillion wealth management-7.00
Financial synergies wealth advisors-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20264347.96%180,048,7902.16%1080.95%23015.00%136-8.11%
Mar 31, 20263873.48%173,625,031-3.72%1050.88%192-4.48%14314.40%
Dec 31, 2025109-70.05%28,066,494-83.45%170.16%61-68.88%32-75.94%
Sep 30, 2025135-62.60%35,434,318-79.06%210.20%61-69.19%61-48.74%
Jun 30, 2025355-6.58%168,942,978-0.75%1020.94%1943.19%118-10.61%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF10.15M6.05%-3.92K
Vanguard Total Stock Mkt Idx Inv5.30M3.18%-4.37K
Vanguard US Total Market Shares ETF5.16M3.17%-174.71K
Vanguard MStar Total Stk Mkt Idx Invest5.32M3.17%16.52K
Vanguard Morn Total Stk Mkt Idx Investor5.30M3.16%-4.37K
Lord Abbett Floating Rate I4.68M2.81%4.68M
iShares Russell 2000 ETF4.24M2.53%-75.36K
Vanguard Small Cap Index3.83M2.28%10.01K
Pacer US Small Cap Cash Cows 100 ETF2.98M1.84%-21.71K
T. Rowe Price U.S. Mid-Cap Val Eq Tr-Z2.64M1.62%-69.71K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 01, 2026Hopkinson Craig C. EVP R&D, Chief Medical OfficerSell$422.87K
Aug 17, 2026Nichols Christian Todd SVP, Chief Commercial OfficerSell$32.97K
Aug 17, 2026Nichols Christian Todd SVP, Chief Commercial OfficerSell$339.97K
Aug 03, 2026snyderman nancy lynn MD-Sell$2.24M
Aug 03, 2026Hopkinson Craig C. EVP R&D, Chief Medical OfficerSell$437.22K

Insider Transactions Trends


DateBuySell
2026 Q3-9
2026 Q2-8
2026 Q1-11
2025 Q4-4
2025 Q3--

ALKS Ownership FAQ


Who Owns Alkermes?

Alkermes shareholders are primarily institutional investors at 108.34%, followed by 1.41% insiders and -9.75% retail investors. The average institutional ownership in Alkermes's industry, Specialty & Generic Drug Manufacturers Stocks, is 35.37%, which Alkermes exceeds.

Who owns the most shares of Alkermes?

Alkermes’s largest shareholders are Blackrock funding, inc. /de (29.24M shares, 17.59%), Blackrock (29.11M shares, 17.33%), and Vanguard group (18.01M shares, 10.91%). Together, they hold 45.83% of Alkermes’s total shares outstanding.

Does Blackrock own Alkermes?

Yes, BlackRock owns 17.33% of Alkermes, totaling 29.11M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 701.49M$. In the last quarter, BlackRock decreased its holdings by -60.933K shares, a -0.21% change.

Who is Alkermes’s biggest shareholder by percentage of total assets invested?

Commodore capital lp is Alkermes’s biggest shareholder by percentage of total assets invested, with 9.36% of its assets in 3M Alkermes shares, valued at 157.18M$.

Who is the top mutual fund holder of Alkermes shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Alkermes shares, with 6.05% of its total shares outstanding invested in 10.15M Alkermes shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools